Tele-rehabilitation After Anterior Cruciate Ligament Reconstruction
Launched by KEXIN WANG, MM · Jan 30, 2024
Trial Information
Current as of June 17, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Tele-rehabilitation After Anterior Cruciate Ligament Reconstruction," is designed to compare two different ways of helping patients recover after surgery for a torn ACL (anterior cruciate ligament). The researchers want to find out if a supervised tele-rehabilitation program, which involves guidance through video calls and online tools, is more effective than doing rehabilitation exercises at home on your own. They will look at important factors like how well patients can move their knee, how much pain they feel, their muscle strength, and overall function after surgery.
To join this study, participants need to be between 18 and 50 years old and have recently suffered a knee injury that requires surgery using their own hamstring tendons. They should also be able to use mobile apps with some help. However, there are some reasons why someone might not be able to participate, like having other serious knee injuries or health issues. If eligible, participants can expect to be part of a program that helps them recover through online sessions, and they will contribute to understanding the best ways to assist recovery after ACL surgery. This trial is currently not recruiting participants yet, so stay tuned for updates if you are interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged between 18 and 50 years at the time of recruit;
- • 2. BMI between 16 and 28 kg/m²;
- • 3. acute unilateral ACL rupture;
- • 4. plan for an ACLR surgery (with autologous hamstrings tendon reconstruction) under arthroscopy;
- • 5. ACL rupture to ACLR within 3 months;
- • 6. Patients can independently use mobile software and WeChat mini programs, and can operate related software through the "Huajiantong" mini program under the guidance of staff;
- Exclusion Criteria:
- • 1. With synthetic tendon reconstruction;
- • 2. Concomitant meniscus lesion which needs operation;
- • 3. Concomitant other ligaments injury which needs operation;
- • 4. Concomitant intra-articular knee fracture;
- • 5. Concomitant fracture or injury which may affect postoperative exercise;
- • 6. Previous history of knee infection, fracture, and surgery;
- • 7. Participate in knee exercises and/or rehabilitation programs in the past three months;
- • 8. Living outside the city, regular return to the hospital for follow-up cannot be guaranteed;
- • 9. Serious cardiopulmonary disease and unable to participate in rehabilitation exercise;
- • 10. Other reasons for exclusion (mental disorders, stroke, pregnancy, etc).
About Kexin Wang, Mm
Kexin Wang, MM, is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a robust background in clinical management and a focus on innovative therapeutic solutions, Kexin leads initiatives that prioritize patient safety and regulatory compliance. Her strategic approach integrates collaboration with healthcare professionals and stakeholders to ensure the effective design and execution of clinical trials. Kexin's expertise in project oversight and data analysis drives the successful development of groundbreaking treatments, contributing to the evolution of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported